The FDA has approved atezolizumab with chemotherapy for adjuvant treatment of stage III dMMR colon cancer after the phase III ...
Researchers have unveiled a breakthrough showing that a subset of colorectal tumors can be eliminated using immunotherapy alone, without chemotherapy or surgery. The finding signals a potential shift ...
The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...
New research shows that synthetic ligands for the orphan nuclear receptors NR4A1 and NR4A2 induce iron-dependent cell death ...
Colon cancer diagnosis involves colonoscopy, imaging, and blood tests, with staging guiding treatment decisions. Stage 1 treatment typically involves surgery, while stage 2 may include chemotherapy ...
Neoadjuvant chemotherapy did not improve disease-free survival compared with upfront surgery in patients with locally advanced colon cancer in a randomized trial. However, neoadjuvant chemotherapy did ...
No colorectal cancer recurrences observed at updated median follow-up of 32.2 months in NEST-1 and 23.5 months in NEST-2 In pMMR/MSS tumors, neoadjuvant BOT+BAL achieved 59% pathologic response, ...
Woman survived colon cancer three times after being diagnosed in her teens, 20s and 30s. She shares her symptoms and how ...
Chronic inflammation may be quietly reshaping the colon and making it more vulnerable to early-onset colorectal cancer. Scientists found that colon tissue in younger patients was stiffer, even in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results